Nasopharyngeal carcinoma other imaging findings: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 19: Line 19:
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}
[[Category:Disease]]
 
[[Category:Types of cancer]]
[[Category:Up-To-Date]]
[[Category:Up-To-Date]]
[[Category:Medicine]]
[[Category:Oncology]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Otolaryngology]]
[[Category:Otolaryngology]]
[[Category:Radiology]]
[[Category: Primary care]]]

Revision as of 14:34, 26 April 2019

Nasopharyngeal carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Nasopharyngeal carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Nasopharyngeal carcinoma other imaging findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Nasopharyngeal carcinoma other imaging findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Nasopharyngeal carcinoma other imaging findings

CDC on Nasopharyngeal carcinoma other imaging findings

Nasopharyngeal carcinoma other imaging findings in the news

Blogs on Nasopharyngeal carcinoma other imaging findings

Directions to Hospitals Treating Nasopharyngeal carcinoma

Risk calculators and risk factors for Nasopharyngeal carcinoma other imaging findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]Faizan Sheraz, M.D. [3]

Overview

Positron emission tomography (PET) scan may be helpful in the diagnosis of nasopharyngeal carcinoma. It is useful in the detection of residual or recurrent tumor after treatment and distant metastasis, prediction of clinical cancer outcome and PET/CT scan is used for NPC staging.

Other Imaging Studies

PET scan may be helpful in the diagnosis of nasopharyngeal carcinoma. PET scan is used for:[1][2][3][4]

References

  1. Nakamoto, Yuji; Osman, Medhat; Wahl, Richard L. (2003). "Prevalence and Patterns of Bone Metastases Detected with Positron Emission Tomography Using F-18 FDG". Clinical Nuclear Medicine. 28 (4): 302–307. doi:10.1097/01.RLU.0000057556.54046.7A. ISSN 0363-9762.
  2. Yen, Ruoh-Fang; Hung, Rey-Long; Pan, Mei-Hsiu; Wang, Yao-Hung; Huang, Kou-Mou; Lui, Louis T.; Kao, Chia-Hung (2003). "18-Fluoro-2-deoxyglucose positron emission tomography in detecting residual/recurrent nasopharyngeal carcinomas and comparison with magnetic resonance imaging". Cancer. 98 (2): 283–287. doi:10.1002/cncr.11519. ISSN 0008-543X.
  3. Chang, K.-P.; Tsang, N.-M.; Liao, C.-T.; Hsu, C.-L.; Chung, M.-J.; Lo, C.-W.; Chan, S.-C.; Ng, S.-H.; Wang, H.-M.; Yen, T.-C. (2012). "Prognostic Significance of 18F-FDG PET Parameters and Plasma Epstein-Barr Virus DNA Load in Patients with Nasopharyngeal Carcinoma". Journal of Nuclear Medicine. 53 (1): 21–28. doi:10.2967/jnumed.111.090696. ISSN 0161-5505.
  4. Yang, Zhongyi; Shi, Qi; Zhang, Yongping; Pan, Herong; Yao, Zhifeng; Hu, Silong; Shi, Wei; Zhu, Beiling; Zhang, Yingjian; Hu, Chaosu (2015). "Pretreatment 18 F-FDG uptake heterogeneity can predict survival in patients with locally advanced nasopharyngeal carcinoma——a retrospective study". Radiation Oncology. 10 (1): 4. doi:10.1186/s13014-014-0268-5. ISSN 1748-717X.

Template:WikiDoc Sources]